|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 39/40 | |||
| A61K 39/21 | |||
| A61P 37/00 | |||
| C07K 16/28 |
| (11) | Number of the document | 2037961 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07812153.0 |
| Date of filing the European patent application | 2007-06-14 | |
| (97) | Date of publication of the European application | 2009-03-25 |
| (45) | Date of publication and mention of the grant of the patent | 2015-11-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/071275 |
| Date | 2007-06-14 |
| (87) | Number | WO 2007/147090 |
| Date | 2007-12-21 |
| (30) | Number | Date | Country code |
| 813903 P | 2006-06-14 | US | |
| 871361 P | 2006-12-21 | US |
| (72) |
KOENIG, Scott, US
WILDER, Ronald, US
BONVINI, Ezio, US
JOHNSON, Leslie, S., US
PILLEMER, Stanley, US
|
| (73) |
MacroGenics, Inc.,
1500 East Gude Drive, Rockville, MD 20850-5307,
US
|
| (54) | METHODS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS USING MONOCLONAL ANTIBODIES WITH REDUCED TOXICITY |
| METHODS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS USING MONOCLONAL ANTIBODIES WITH REDUCED TOXICITY |